ORCA Therapeutics Competitors and Similar CompaniesClear all

ORCA Therapeutics's competitors and similar companies include Clovis Oncology, HUYA Bioscience International, Deciphera Pharmaceuticals and PharmaEssentia.

	ORCA Therapeutics ORCA Therapeutics is a biopharmaceutical company designing and developing immunotherapies for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA).	Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.	HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.	PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
Founding Date	Founding Date 2005	Founding Date 2009	Founding Date 2004	Founding Date 2003	Founding Date 2003
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations 's-Hertogenbosch, NL HQ Amsterdam, NL Nijmegen, NL	Locations Boulder, US HQ Paris, FR München, DE Dublin, IE Milano, IT Madrid, ES Zürich, CH see more	Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more	Locations Waltham, US HQ Lawrence, US	Locations Taipei, TW HQ Shinjuku City, JP Burlington, US
Employees	Employees 6	Employees 4843% increase	Employees 1113% increase	Employees 35037% increase	Employees 4897% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 10.6 m	Valuation ($) N/A	Valuation ($) 2.2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $148.8m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $163.4m (FY, 2023)	Revenue (est.) NT$15.6b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $3.7m (FY, 2023)	Cost of goods NT$1.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $159.6m (FY, 2023)	Gross profit NT$14.4b (FY, 2025)
Net income	Net income N/A	Net income ($264.5m) (FY, 2021)	Net income N/A	Net income ($194.9m) (FY, 2023)	Net income NT$5b (FY, 2025)
Funding
Latest funding round	Latest funding round $ 1.7m (about 10 years ago)	Latest funding round N/A	Latest funding round $ 7.6m (over 14 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 1.7m	Total funding raised $ 357m	Total funding raised $ 12.6m	Total funding raised $ 714m	Total funding raised N/A